Russell Investments Group, Ltd. Invitae Corp Transaction History

Russell Investments Group, Ltd.

$61.8 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$1.05 - $1.63 $302 - $469	-288 Reduced 86.23%	46 $0
Q1 2023 May 09, 2023	BUY	$1.2 - $2.73 $400 - $911	334 New	334 $0
Q2 2022 Jul 29, 2022	SELL	$2.13 - $9.01 $3,446 - $14,578	-1,618 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$6.28 - $15.59 $76,735 - $190,494	-12,219 Reduced 88.31%	1,618 $12,000
Q4 2021 Jan 21, 2022	SELL	$14.7 - $28.67 $315,079 - $614,512	-21,434 Reduced 60.77%	13,837 $210,000

Q3 2021 Nov 08, 2021	BUY	$24.31 - $33.6 $466,995 - $645,456	19,210 Added 119.61%	35,271 $1 Million
Q2 2021 Aug 04, 2021	SELL	$26.09 - $40.4 $304,966 - $472,235	-11,689 Reduced 42.12%	16,061 $541,000
Q1 2021 May 10, 2021	BUY	$33.06 - $56.93 $276,811 - $476,674	8,373 Added 43.21%	27,750 $1.06 Million
Q4 2020 Feb 08, 2021	BUY	$39.09 - $57.4 $206,199 - $302,785	5,275 Added 37.41%	19,377 $810,000
Q2 2020 Aug 05, 2020	SELL	$11.71 - $30.29 $1.15 Million - $2.98 Million	-98,281 Reduced 87.45%	14,102 $426,000
Q1 2020 May 06, 2020	SELL	$7.64 - $27.5 $168,721 - $607,310	-22,084 Reduced 16.42%	112,383 $1.54 Million
Q4 2019 Jan 29, 2020	BUY	$15.02 - $20.57 $945,358 - $1.29 Million	62,940 Added 87.99%	134,467 $2.17 Million
Q3 2019 Nov 01, 2019	SELL	$18.85 - $27.5 $552,455 - $805,970	-29,308 Reduced 29.07%	71,527 $1.38 Million
Q2 2019 Aug 09, 2019	BUY	$17.37 - $26.27 $667,060 - $1.01 Million	38,403 Added 61.51%	100,835 $2.37 Million
Q1 2019 May 13, 2019	BUY	$10.65 - $25.75 $470,016 - $1.14 Million	44,133 Added 241.18%	62,432 $1.46 Million
Q4 2018 Feb 11, 2019	SELL	$9.26 - $16.38 $865,578 - $1.53 Million	-93,475 Reduced 83.63%	18,299 $200,000
Q3 2018 Oct 26, 2018	BUY	$7.54 - $18.31 $842,775 - $2.05 Million	111,774 New	111,774 $1.87 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account